SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Spine-Tech (SPYN) -- Ignore unavailable to you. Want to Upgrade?

To: studdog who wrote (189)10/24/1997 6:43:00 PM
From: jbershad  Read Replies (1) | Respond to of 242
 
stock cheap below 45. H&Q just raised softmore danik to
a strong buy.

Jerry



To: studdog who wrote (189)10/26/1997 9:26:00 PM
From: jbershad  Respond to of 242
 
SDG came out with 23% increase in 3-Q per.
earnings stock shoot up about 4 pts. Smith
Barney upgraded to buy from outperform. H&Q
have strong buy on it. I might pick up a
100 shares if this thing ever drops back
to maybe 60 or close.

Jerry



To: studdog who wrote (189)10/28/1997 6:51:00 PM
From: Royalcoachman  Respond to of 242
 
There certainly is room for more than on competitor in this market. But why is the market capitalization for SPYN greater than the entire market for spine implants. Could SPYN be incredibly overvalued? You can "bet the canoe" on that.

David


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News